Current status of the treatment of mCRC with EGFR inhibitors

Date 05 March 2016
Event ESMO Symposium on Signalling Pathways in Cancer 2016
Session Targeting the EGFR/HER family in CRC
Topics Anti-Cancer Agents & Biologic Therapy
Colon Cancer
Rectal Cancer
Personalised Medicine
Presenter Salvatore Siena
Authors S. Siena
  • Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, 20162 - Milano/IT